ZEO Scientifix FY25 revenue rises 12.5% to USD 5.2 million
I'm PortAI, I can summarize articles.
ZEO Scientifix Inc. reported a 12.5% increase in FY25 revenues, totaling USD 5.2 million, for the fiscal year ending October 31, 2025. The Higher Concentration Allogenic Aesthetic Biologics segment contributed USD 2.2 million, while the Lower Concentration segment generated USD 1.4 million. The company relies on additional investment capital for ongoing expenses and R&D, and does not anticipate recent accounting changes to significantly impact its financial condition.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments